MENU
NRSN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NeuroSense Therapeutics (NRSN) Ownership - Who owns NeuroSense Therapeutics?
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases... Show more
Profile
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
23.23M
P/E Ratio
N/A
Total Cash
344K
Projected Growth
N/A
Total Debt
19K
Revenue
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NRSN
Capitalization
23.2M
P/E Ratio
N/A
Risk (Beta)
1.23
Dividend Yield
N/A
Total Cash
344K
Total Cash/Share
0.01
Total Debt
19K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-2.82M
P/B Ratio
8.99
Cash Flow
N/A
Earnings
-0.76
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
0.21
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-10.41M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-400.91
Shares Held By Institutions
793K
Shares Outstanding - Current
23.2M
Total Liabilities
3.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-17.754
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11 HaMenofim Street, Building B
Phone
+972 97996183
Employees
14
Web
https://www.neurosense-tx.com